Taking responsibility for a better world
Crucell’s mission to bring innovation to global health reflects a deep commitment to improving the lives of people worldwide. We see this as part of our corporate social responsibility (CSR)—a responsibility that underpins everything we do as a global organization and as individuals united by a common purpose. For several years we have been working to develop our approach to CSR, with the goal of maximizing our contribution to society and minimizing our environmental impact. This report highlights the recent steps we have taken on our journey and outlines the road ahead.
Crucell is making great strides with the implementation of a comprehensive policy for integrating sustainability practices in our organization. In 2009, we outlined our CSR 4P policy framework incorporating the four ‘Ps’ of Performance, People, Planet and Philanthropy. In 2010, we focused on bringing this policy to life in our global organization, with substantial success.
A first step in this process was to establish a CSR Working Group, which is responsible for driving continuous progress in the four P-categories. With strong support from Crucell’s Management Board and many Crucell employees worldwide, this group has risen to the challenge of introducing a consistent approach to CSR development, information management and reporting. Despite the complexity of harmonizing data and definitions across departments and sites, close to full data coverage has been achieved. This will enable us to measure our progress and further improve both target setting and reporting in the years ahead.
At the same time, we have been seizing opportunities for increasing our contribution to society right here and now. The rapid evolution of ‘Footprint’, our community outreach program, is one exciting example of this. The introduction of global learning and development programs for Crucell employees is another. Wherever possible, we have achieved quick wins regarding our environmental impact, while working towards a more comprehensive approach in the longer term.
Looking to the future, we are delighted that talks we held with Johnson & Johnson during 2010 have resulted in Crucell becoming the center of excellence for vaccines within the world’s largest and possibly most respected healthcare company. As a member of the Johnson & Johnson Family of Companies, we can do so much more to make the world we live in a healthier and safer place. This is our core business, our passion and a key component of our CSR program.
On the threshold of this new era, we have compiled this report in order to update our stakeholders on the current status of our CSR program, the contribution we made to society during 2010 and our plans for the future.
About this report
The information in this report covers the global Crucell organization during the full calendar year 2010, unless otherwise stated. Crucell has not sought external verification of the information presented here as our current priority is to facilitate the smooth working of our newly implemented systems for CSR development.